Drugs News and Research

RSS

Norrin treatment prevents vision loss in diabetic rats

Over 100 million people in the U.S. are affected by diabetic retinopathy, a complication of diabetes that affects the eyes.

30 Oct 2026

Insilico Medicine leader shares AI-driven drug discovery insights in Shanghai and Dubai

Dr. Jue Wang, Head of Global Business Development at Insilico Medicine, has been invited to attend the China Healthcare Summit in Shanghai. On the afternoon of November 3 at 16:45, she will deliver a keynote speech in the panel titled: "THE COMMODITIZATION TRAP: WHO WINS WHEN EVERYONE HAS THE SAME AI?"

30 Oct 2026

Targeting specific enzyme reverses radiation-induced immune suppression in cancer

Researchers at the University of Chicago identified a mechanism to make immune cells reprogrammed by radiation therapy attack tumors rather than protect them.

30 Oct 2026

Targeting ANO6 protein weakens pancreatic cancer and boosts immunity

Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that tumor growth can be slowed and immune suppression can be reduced in preclinical trials by blocking a particular protein, called anoctamin 6 (ANO6).

30 Oct 2026

Tailoring prostate cancer radiotherapy to body clock could cut long-term side effects

A study by Leicester researchers shows that the timing of radiotherapy treatment may be as important as how it is given for prostate cancer patients.

30 Oct 2026

Online reviews reveal troubling side effects of insomnia drug lemborexant

Researchers from Rutgers and other universities analyzed hundreds of online reviews on lemborexant – and learned that about 1 in 4 of the reviewers stopped or planned to stop taking the prescription medication used to treat insomnia.

29 Oct 2026

Major studies identify accurate non-invasive tests for liver disease

Two major international studies have delivered the strongest evidence to date on which non-invasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, reducing reliance on liver biopsy.

29 Oct 2026

New mechanism helps cancer cells selectively produce proteins that drive tumor growth

A previously unknown mechanism helps cancer cells selectively produce proteins that drive tumor growth - such as KRAS - in common cancers, according to new research from The University of Texas MD Anderson Cancer Center.

29 Oct 2026

Hospital sewers promote antibiotic resistant bacteria, new study finds

Antibiotics excreted by patients promote antibiotic-resistant bacteria in hospital sewers, according to a new study by researchers at the University of Gothenburg, Sweden.

29 Oct 2026

Amino acid restores power to last-resort antibiotics

Worldwide, antibiotic resistance is associated with millions of deaths every year, and the World Health Organization warns that the number of resistant infections is rising.

29 Oct 2026

Novel transporter protein discovery opens new pathways for central nervous system therapies

Researchers at the University of Eastern Finland have identified a transporter protein with the potential to open new avenues for improving creatine delivery into the brain and for developing other therapies targeting the central nervous system.

29 Oct 2026

Targeted drug combination extends survival in advanced kidney cancer

Results of a phase 1/2 trial led by Roswell Park Comprehensive Cancer Center show that combining the targeted therapies bevacizumab (Avastin) and pazopanib (Votrient) significantly extends both progression-free and overall survival in patients with the most common type of kidney cancer.

28 Oct 2026

Landmark studies map how genetic differences drive human diseases

In three landmark studies published in Nature today, Australian researchers have made major advances in our understanding of how genetic differences between people influence disease.

28 Oct 2026

Review highlights essential neurological considerations for gender dysphoria care

Gender dysphoria involves distress caused by a mismatch between a person's gender identity and sex assigned at birth.

28 Oct 2026

Lab-on-a-chip technology helps predict childhood leukemia treatment responses

More than 120,000 people in the U.S. are living with acute lymphoblastic leukemia (ALL), and 6,000 new cases are diagnosed each year. Of those, more than 3,500 will be in children.

27 Oct 2026

New research center aims to accelerate hepatitis C vaccine development

The shifty hepatitis C virus (HCV) has a knack for outmaneuvering the immune system. Its secret is an especially high mutation rate, which has generated an abundance of viral variants with extreme genetic diversity.

27 Oct 2026

Low vitamin B12 is linked to heart disease. Supplements tell a different story

A narrative review published in Nutrition Journal examines how vitamin B12 deficiency may contribute to cardiovascular disease through elevated homocysteine, endothelial dysfunction, oxidative stress and altered methylation. The authors found that B12 supplementation has not consistently prevented heart attacks or cardiovascular deaths in clinical trials, although combined B-vitamin therapy may modestly reduce stroke risk, particularly in populations without folic acid fortification.

27 Oct 2026

High-scoring endocrinologists are more likely to prescribe key diabetes drugs

Endocrinologists who scored highest on the American Board of Internal Medicine's Longitudinal Knowledge Assessment (LKA®) were more likely to prescribe a key diabetes drug class following a treatment guidelines update compared to doctors with lower scores.

27 Oct 2026

Baylor researchers discover how glioblastoma hijacks nearby brain cells

Researchers at Baylor College of Medicine have discovered a new strategy that glioblastoma, the most common and aggressive form of adult brain cancer, uses to fuel its own growth.

27 Oct 2026

Opioid drop drives decline in drug-related heart infection hospitalizations

A new national study found that hospitalizations for serious heart infections associated with drug use are declining after years of increases, driven largely by a decrease in opioid-associated cases.

27 Oct 2026